AstraZeneca investors to revolt against CEO Pascal Soriot’s pay yet again: report

16th April 2020 Uncategorised 0

AstraZeneca investors are once again taking issues with CEO Pascal Soriot’s compensation package, just like they have repeatedly in the past few years. This time, they don’t like his pension contribution, how the board calculated his annual bonus and a planned increase of maximum long-term incentive awards.

More: AstraZeneca investors to revolt against CEO Pascal Soriot’s pay yet again: report
Source: fierce